CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Theragen Etex Co Ltd (Parent) is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Theragen Etex Co Ltd (Parent)
58, Sandan-ro 68beon-gil, Danwon-gu
Phone: +82 234637111p:+82 234637111 ANSAN, 15438  South Korea Fax: +82 234638111f:+82 234638111
Business Summary
THERAGEN ETEX CO.LTD. is a Korea-based company engaged in the industrial equipment business, healthcare and genome business and pharmaceutical business. The Company operates its business through three divisions: flat panel display (FPD) manufacturing equipment division, which provides loading and unloading systems, printed circuit board (PCB) bonding systems, battery washing lines and laser systems; healthcare and genome division engages in the provision of genome analysis services and others, and pharmaceutical division engages in the manufacture of digestive system remedies, antibiotics, remedies for fever, circulatory system remedies, respiration system remedies, treatment for chronic hepatitis, diabetes remedies, psychotropic agents, osteoporosis treatments and others.
(Source: ARS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/201612/31/2016Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
3559 Special industry machinery, not elsewhere classified
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President Sang GyuKim 63 1/1/2012
Co-Chief Executive Officer, Vice Chairman Jin EopGoh 71 4/3/2023 4/13/2006
Co-Chief Executive Officer, Director Si HongPark 54 4/3/2023 4/3/2023
12 additional Officers and Directors records available in full report.

Business Names
Business Name
Essel-Tech Co., Ltd. (Parent)
THERAGEN CO.,LTD. (Parent)

General Information
Number of Employees: 212 (As of 9/30/2012)
Outstanding Shares: 32,005,379 (As of 7/30/2021)
Shareholders: 2,047
Fax Number: +82 234638111


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, August 30, 2023